These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 29416690)
1. High mobility group protein A2 overexpression indicates poor prognosis for cancer patients: a meta-analysis. Nie D; Zhang L; Guo Q; Mao X Oncotarget; 2018 Jan; 9(1):1237-1247. PubMed ID: 29416690 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of high mobility group protein A2 (HMGA2) over-expression in cancer progression. Binabaj MM; Soleimani A; Rahmani F; Avan A; Khazaei M; Fiuji H; Soleimanpour S; Ryzhikov M; Ferns GA; Bahrami A; Hassanian SM Gene; 2019 Jul; 706():131-139. PubMed ID: 31055021 [TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic significance of HMGA2 overexpression in gastric cancer: a meta-analysis. Zhu J; Wang H; Xu S; Hao Y Oncotarget; 2017 Nov; 8(59):100478-100489. PubMed ID: 29245994 [TBL] [Abstract][Full Text] [Related]
4. Prognostic Value of HMGA2 in Human Cancers: A Meta-Analysis Based on Literatures and TCGA Datasets. Huang B; Yang J; Cheng Q; Xu P; Wang J; Zhang Z; Fan W; Wang P; Yu M Front Physiol; 2018; 9():776. PubMed ID: 29997523 [No Abstract] [Full Text] [Related]
5. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma. Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913 [TBL] [Abstract][Full Text] [Related]
6. High mobility group A protein-2 as a tumor cancer diagnostic and prognostic marker: a systematic review and meta-analysis. Thi-Hai Pham Y; Utuama O; Thomas CE; Park JA; La Vecchia C; Risch HA; Tran CT; Le TV; Boffetta P; Raskin L; Luu HN Eur J Cancer Prev; 2020 Nov; 29(6):565-581. PubMed ID: 32898013 [TBL] [Abstract][Full Text] [Related]
7. Survival and Clinicopathological Significance of SIRT1 Expression in Cancers: A Meta-Analysis. Sun M; Du M; Zhang W; Xiong S; Gong X; Lei P; Zha J; Zhu H; Li H; Huang D; Gu X Front Endocrinol (Lausanne); 2019; 10():121. PubMed ID: 30930849 [No Abstract] [Full Text] [Related]
8. High HMGA2 Expression Correlates with Reduced Recurrence-free Survival and Poor Overall Survival in Oral Squamous Cell Carcinoma. Fang CY; Liew PL; Chen CL; Lin YH; Fang CL; Chen WY Anticancer Res; 2017 Apr; 37(4):1891-1899. PubMed ID: 28373457 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA CCAT2 can predict metastasis and poor prognosis: A meta-analysis. Fan YH; Fang H; Ji CX; Xie H; Xiao B; Zhu XG Clin Chim Acta; 2017 Mar; 466():120-126. PubMed ID: 28089750 [TBL] [Abstract][Full Text] [Related]
10. High-mobility-group A2 overexpression provokes a poor prognosis of gastric cancer through the epithelial-mesenchymal transition. Lee J; Ha S; Jung CK; Lee HH Int J Oncol; 2015; 46(6):2431-8. PubMed ID: 25845850 [TBL] [Abstract][Full Text] [Related]
11. Overexpression of HMGA2 promotes tongue cancer metastasis through EMT pathway. Zhao XP; Zhang H; Jiao JY; Tang DX; Wu YL; Pan CB J Transl Med; 2016 Jan; 14():26. PubMed ID: 26818837 [TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of TAZ expression in various cancers: a meta-analysis. Feng J; Ren P; Gou J; Li Z Onco Targets Ther; 2016; 9():5235-44. PubMed ID: 27601916 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of ANXA2 predicts adverse outcomes of patients with malignant tumors: a systematic review and meta-analysis. Liu X; Ma D; Jing X; Wang B; Yang W; Qiu W Med Oncol; 2015 Jan; 32(1):392. PubMed ID: 25476478 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases. Ye Z; Zhang X; Luo Y; Li S; Huang L; Li Z; Li P; Chen G PLoS One; 2016; 11(9):e0163162. PubMed ID: 27657690 [TBL] [Abstract][Full Text] [Related]
15. HMGA2 is associated with epithelial-mesenchymal transition and can predict poor prognosis in nasopharyngeal carcinoma. Xia YY; Yin L; Tian H; Guo WJ; Jiang N; Jiang XS; Wu J; Chen M; Wu JZ; He X Onco Targets Ther; 2015; 8():169-76. PubMed ID: 25653540 [TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of tumor-associated macrophages in ovarian cancer: A meta-analysis. Yuan X; Zhang J; Li D; Mao Y; Mo F; Du W; Ma X Gynecol Oncol; 2017 Oct; 147(1):181-187. PubMed ID: 28698008 [TBL] [Abstract][Full Text] [Related]
17. Prognostic value of flotillins (flotillin-1 and flotillin-2) in human cancers: A meta-analysis. Deng Y; Ge P; Tian T; Dai C; Wang M; Lin S; Liu K; Zheng Y; Xu P; Zhou L; Hao Q; Dai Z Clin Chim Acta; 2018 Jun; 481():90-98. PubMed ID: 29499201 [TBL] [Abstract][Full Text] [Related]
18. Role of CXCR7 as a Common Predictor for Prognosis in Solid Tumors: a Meta-Analysis. Zhao Q; Zhang P; Qin G; Ren F; Zheng Y; Qiao Y; Sun T; Zhang Y J Cancer; 2018; 9(17):3138-3148. PubMed ID: 30210637 [No Abstract] [Full Text] [Related]
19. High Poly(ADP-Ribose) Polymerase Expression Does Relate to Poor Survival in Solid Cancers: A Systematic Review and Meta-Analysis. Thakur N; Yim K; Abdul-Ghafar J; Seo KJ; Chong Y Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830749 [TBL] [Abstract][Full Text] [Related]
20. Clinicopathologic and prognostic significance of C-reactive protein/albumin ratio in patients with solid tumors: an updated systemic review and meta-analysis. Wu J; Tan W; Chen L; Huang Z; Mai S Oncotarget; 2018 Mar; 9(17):13934-13947. PubMed ID: 29568406 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]